Do GLP-1 Drugs Affect Hormones or Fertility?
GLP-1’s continue to be a hot topic of conversation. Most recently, attention has shifted to their potential effects on women's hormones and fertility. Social media has been flooded with discussions about "Ozempic babies," menstrual cycle changes, and hormone regulation. But is there any established clinical evidence to support the growing number of anecdotal reports online?
To get to the bottom of it, we interviewed AEDIT founder and board-certified facial plastic and reconstructive surgeon Dr. William Kennedy to answer all of our questions. Ahead, we’ll clarify what researchers currently know, what remains uncertain, and why rapid weight loss itself may influence reproductive function.
Why are fertility conversations surrounding GLP-1 drugs suddenly everywhere?
Fertility conversations surrounding GLP-1 medications have gained momentum as more women share stories of unexpected pregnancies, menstrual changes, and other reproductive health experiences while taking drugs like Ozempic, Wegovy, and Mounjaro. Social media has amplified these anecdotes, fueling curiosity about whether GLP-1 medications may influence hormones, ovulation, and fertility. At the same time, growing awareness of the connection between metabolic health and reproductive function has prompted patients and healthcare providers alike to ask new questions about these medications. While research in this area remains limited, the volume of personal stories online has made fertility one of the most talked-about aspects of the GLP-1 conversation.
How should patients interpret anecdotal social-media claims?
Social media can be a goldmine of information, but it’s critical to remember that personal anecdotes are not scientific evidence. While online reports of unexpected pregnancies, menstrual changes, and other reproductive health experiences have helped spark conversation around the relationship between GLP-1 medications and fertility, they don’t prove cause and effect. It's best to view TikToks and Reels as conversation starters rather than definitive answers and look to healthcare providers and peer-reviewed research for guidance.
So, can semaglutide change hormones?
Semaglutide does not directly alter hormone production, but it can influence several hormonal pathways throughout the body. By improving insulin sensitivity, promoting weight loss, and affecting appetite-regulating hormones, semaglutide can create downstream changes that impact metabolic and reproductive health. Dr. Kennedy explains, “These changes may support fertility by helping restore hormonal balance and ovulatory function. Insulin resistance can disrupt the hormonal signals that regulate ovulation and contribute to conditions such as polycystic ovary syndrome (PCOS). By improving insulin sensitivity and reducing excess weight, semaglutide may help normalize these signals, promote more regular menstrual cycles, and create a more favorable environment for conception.”
Can Ozempic affect your period?
While there isn't enough research to support a direct cause-and-effect relationship between Ozempic and menstrual changes, anecdotal reports suggest that GLP-1 medications may affect some women's cycles, varying from missed periods, irregular cycles, or changes in menstrual flow after starting Ozempic. That said, it's difficult to determine whether these shifts are a direct effect of the medication or the result of rapid weight loss, improved insulin sensitivity, and hormonal fluctuations that often accompanies its metabolic effects.
Can weight loss affect menstrual cycles?
Significant weight loss can affect the menstrual cycle because it alters the body's hormonal balance and energy availability. When the body experiences rapid weight loss, reproductive hormones can fluctuate, which can result in missed periods, irregular cycles, or changes in menstrual flow. In some cases, particularly for those with obesity or PCOS, weight loss may have the opposite effect and can help stimulate ovulation and improve cycle regularity. The impact often depends on an individual's starting weight, overall health, and the amount and pace of weight loss.
How might GLP-1s affect women with PCOS differently?
Women with PCOS may experience unique benefits from GLP-1 medications because the condition is closely linked to insulin resistance and metabolic dysfunction. By improving insulin sensitivity and supporting weight loss, GLP-1 medications may help address some of the underlying factors that contribute to irregular menstrual cycles and ovulatory dysfunction. Research has found that women with PCOS who take GLP-1 receptor agonists may experience improvements in menstrual regularity, ovulation, and other metabolic markers. While these medications are not approved as fertility treatments, their effects on weight and insulin regulation may have important implications for reproductive health in women with PCOS.
Do GLP-1 medications affect fertility?
There is currently no evidence that GLP-1 medications directly increase or decrease fertility. However, because these medications can promote significant weight loss and improve insulin sensitivity, they may indirectly support reproductive health in some individuals, particularly for women with PCOS. As metabolic health improves, some women may experience more regular menstrual cycles and restored ovulation, which can increase the likelihood of pregnancy. While research is ongoing, experts generally believe any fertility-related effects are more likely tied to improvements in overall metabolic function than the medications themselves.
Do GLP-1 drugs affect birth control?
Most GLP-1 medications are not known to interfere with hormonal birth control. However, tirzepatide, sold under the brand names Mounjaro and Zepbound, may reduce the effectiveness of oral contraceptives. Because tirzepatide slows stomach emptying, it can affect how certain medications are absorbed. As a result, patients taking tirzepatide may be advised to use a non-oral contraceptive method or a backup form of birth control, particularly when starting treatment or increasing their dose. “For individuals taking semaglutide who want to avoid pregnancy, long-acting reversible contraceptives such as IUDs and contraceptive implants may be preferable options,” says Dr. Kennedy. “Unlike oral contraceptives, these methods do not rely on absorption through the gastrointestinal tract, making them less susceptible to factors such as delayed gastric emptying, nausea, vomiting, or diarrhea. They also provide highly effective, low-maintenance pregnancy prevention, which can be particularly beneficial during periods of significant weight loss or lifestyle changes.”
What are Ozempic babies?
"Ozempic babies" is a term that has emerged on social media to describe unexpected pregnancies that occur while taking GLP-1 medications. While the medications themselves are not fertility treatments, they may be linked to improvements in metabolic health, weight loss, and insulin sensitivity, all of which can help restore ovulation in some women. That being said, the term is a bit misleading because it’s actually tirzepatide, not semaglutide, that can interfere with oral contraceptive absorption.
Is tirzepatide safe for women trying to conceive?
Tirzepatide is not recommended for women who are actively trying to conceive because there are concerns about potential risks to fetal development. Most healthcare providers recommend stopping treatment at least two months prior to trying to conceive because tirzepatide can remain in the body for several weeks after the last dose. Women who are planning to conceive should discuss their timeline and treatment plan with their healthcare provider to determine the safest approach.
What do doctors recommend for women trying to conceive?
Most healthcare providers recommend discontinuing GLP-1 medications before trying to conceive since there is limited data on their safety during pregnancy. When discontinuing GLP-1 treatments, it’s important to continue practicing healthy lifestyle habits that support fertility. Since every body is different, there’s no one-size-fits-all approach, but Dr. Kennedy recommends focusing on sustainable nutrition, regular physical activity, stress management, and adequate sleep to help optimize fertility and support overall reproductive health.
What does current clinical evidence actually show?
The strongest clinical evidence centers on women with PCOS, where GLP-1 receptor agonists have been associated with improved menstrual regularity, higher natural pregnancy rates, and improvements in weight and insulin resistance. However, the data is still limited, and newer reviews caution that evidence for reproductive outcomes remains low-certainty. Dr. Kennedy highlights, “While research specifically examining GLP-1 medications and fertility is still relatively limited, we know that these medications can improve several factors that play an important role in reproductive health. GLP-1 receptor agonists can help reduce chronic inflammation, improve insulin sensitivity, promote weight loss when appropriate, and support more balanced hormone signaling. For individuals whose fertility is being affected by metabolic conditions such as obesity, insulin resistance, or PCOS, improvements in these areas may help create a more favorable environment for ovulation and conception.”
